{"mainPropery":{"diseaseId":6233,"diseaseName":"Cystic fibrosis","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/6233/cystic-fibrosis","synonyms":["Mucoviscidosis","CF"],"synonyms-with-source":[{"name":"Mucoviscidosis"},{"name":"CF"}],"identifiers":[{"identifierType":"OMIM","identifierId":"219700"},{"identifierType":"ORPHANET","identifierId":"586"}]},"diseaseCategories":[{"diseaseTypeId":5,"diseaseTypeName":"Congenital and Genetic Diseases","source":"Orphanet"},{"diseaseTypeId":6,"diseaseTypeName":"Digestive Diseases","source":"Orphanet"},{"diseaseTypeId":21,"diseaseTypeName":"Lung Diseases","source":"Orphanet"},{"diseaseTypeId":24,"diseaseTypeName":"Male Reproductive Diseases"},{"diseaseTypeId":37,"diseaseTypeName":"Newborn Screening"}],"organizations":[{"resourceID":27,"resourceName":"Cystic Fibrosis Foundation","abbreviation":"","address1":"4550 Montgomery Ave.","address2":"Suite 1100 N","address3":"","address4":"","address5":"","city":"Bethesda","state":"MD","zip":"20814","country":"United States","phone":"+1-301-951-4422 ","tty":"","tollFree":" 1-800-FIGHTCF (800-344-4823)","fax":"+1-301-951-6378 ","email":"info@cff.org","url":"https://www.cff.org/","freeText":""},{"resourceID":30,"resourceName":"Cystic Fibrosis Research, Inc.","abbreviation":"","address1":"1731 Embarcadero Road, Suite 210 ","address2":"","address3":"","address4":"","address5":"","city":"Palo Alto","state":"CA","zip":"94303","country":"United States","phone":"+1-650-665-7576","tty":"","tollFree":"1-855-237-4669","fax":"+1-650-561-4074","email":"cfri@cfri.org","url":"https://cfri.org/","freeText":""},{"resourceID":32,"resourceName":"Jewish Genetic Disease Consortium (JGDC)","abbreviation":"","address1":"450 West End Ave., 6A","address2":"","address3":"","address4":"","address5":"","city":"New York","state":"NY","zip":"10024","country":"United States","phone":"855-642-6900","tty":"","tollFree":"866-370-GENE (4363)","fax":"212-873-7892","email":"info@jewishgeneticdiseases.org","url":"http://www.JewishGeneticDiseases.org","freeText":""},{"resourceID":254,"resourceName":"American Lung Association","abbreviation":"","address1":"55 W. Wacker Drive, Suite 1150","address2":"","address3":"","address4":"","address5":"","city":"Chicago","state":"IL","zip":"60601","country":"United States","phone":"","tty":"","tollFree":"1-800-548-8252 (1-800-LUNGUSA)","fax":"","email":"info@lung.org","url":"https://www.lung.org/","freeText":""},{"resourceID":932,"resourceName":"March of Dimes","address1":"1275 Mamaroneck Avenue","city":"White Plains","state":"NY","zip":"10605","country":"United States","phone":"914-997-4488","tollFree":"888-663-4637","fax":"914-997-4763","email":"http://www.marchofdimes.com/contactus.html","url":"http://www.marchofdimes.com/"}],"resource descriptions":[{"id":7,"resourceId":10,"resourceName":"Online Mendelian Inheritance in Man (OMIM)","descriptionText":"<a href='http://www.omim.org/219700' target='_blank'>Online Mendelian Inheritance in Man (OMIM)</a> is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.&nbsp;<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=DetailsSearch&Term=%22Cystic+Fibrosis%22%5BMesh%5D+AND+%28%222003%2F12%2F27%22%5BEDat%5D+%3A+%222008%2F12%2F24%22%5BEDat%5D+AND+%222003%2F12%2F27%22%5BPDat%5D+%3A+%222008%2F12%2F24%22%5BPDat%5D+AND+%22humans%22%5BMeSH+Terms%5D%29' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Cystic fibrosis. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":9,"resourceId":12,"resourceName":"ClinicalTrials.gov","descriptionText":"<a href='http://www.clinicaltrials.gov/ct2/results?cond=%22Cystic+fibrosis%22' target='_blank'>ClinicalTrials.gov</a> lists trials that are related to Cystic fibrosis. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies. <br />\r\n<br />\r\n<em><strong>Please note:</strong>&nbsp;Studies listed on the&nbsp;ClinicalTrials.gov&nbsp;website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.</em>","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":10,"resourceId":13,"resourceName":"MedlinePlus Genetics","descriptionText":"<a href='http://www.ghr.nlm.nih.gov/condition=cysticfibrosis' target='_blank'>Genetics Home Reference (GHR)</a> contains information on Cystic fibrosis. This website is maintained by the National Library of Medicine.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":350,"resourceId":1167,"resourceName":"Baby's First Test","descriptionText":"<a href='https://www.babysfirsttest.org/newborn-screening/conditions/cystic-fibrosis-cf' target='_blank'>Baby's First Test</a> is the nation's newborn screening education center for families and providers. This site provides information and resources about screening at the local, state, and national levels and serves as the Clearinghouse for newborn screening information.","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Newborn Screening"},{"id":824,"resourceId":1525,"resourceName":"Newborn Screening Coding and Terminology Guide Cystic fibrosis","descriptionText":"The <a href='http://newbornscreeningcodes.nlm.nih.gov/nb/sc/condition/CF ' target='_blank'>Newborn Screening Coding and Terminology Guide</a> has information on the standard codes used for  newborn screening tests. Using these standards helps compare data across different laboratories. This resource was created by the National Library of Medicine.","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Newborn Screening"},{"id":914,"resourceId":1617,"resourceName":"Childhood Liver Disease Research and Education Network (formerly RDCRN)","descriptionText":"<p>The <a href='http://www.childrennetwork.org/ ' target='_blank'>Childhood Liver Disease Research and Education Network (ChiLDREN)</a> is a team of doctors, nurses, research coordinators, and research labs throughout the U.S., working together to improve the lives of people with rare liver diseases through research. Current studies are enrolling people with Alagille syndrome, alpha one-antitrypsin deficiency, bile acid synthesis defects, biliary atresia, cystic fibrosis liver disease, idiopathic neonatal hepatitis, mitochondrial hepatopathies, and progressive familial intrahepatic cholestasis. Click on the link above to learn more.</p><p>Visit the following link to find the participating research center nearest you.<br /><a href='http://childrennetwork.org/centers.html ' target='_blank'>http://childrennetwork.org/centers.html</a></p>","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":1286,"resourceId":1946,"resourceName":"ACMG cystic fibrosis screening","descriptionText":"In 2002, the <a href='http://www.acmg.net/StaticContent/StaticPages/CF_Mutation.pdf ' target='_blank'>American College of Medical Genetics (ACMG) Cystic Fibrosis (CF) Carrier Screening Working Group</a>, as part of an ongoing effort to ensure that the cystic fibrosis carrier screening programs are current, initiated a review of the scientific literature and other available data and practices.&nbsp; The Working Group summarized its major recommendations&nbsp;with the supporting justification for these decisions in an article by Watson <em>et al</em>. titled \"Cystic&nbsp;fibrosis population carrier screening: 2004 revision of&nbsp;American College of Medical Genetics.\"&nbsp; To access this policy statement, visit the link above.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Selected Full-Text Journal Articles"},{"id":1292,"resourceId":1949,"resourceName":"American College of Obstetricians and Gynecologists (ACOG)","descriptionText":"The American College of Obstetricians and Gynecologists (ACOG) has information on <a href='http://www.acog.org/~/media/For%20Patients/faq171.pdf?dmc=1&amp;ts=20130205T0919547168 ' target='_blank'>Cystic Fibrosis: Prenatal Screening and Diagnosis</a>.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1321,"resourceId":1982,"resourceName":"National Newborn Screening and Global Resource Center","descriptionText":"<a href='https://www.newbornscreening.info/iva-isovaleric-acidemia/' target='_blank'>National Newborn Screening and Global Resource Center</a> (NNSGRC) provides information and resources in the area of newborn screening and genetics to benefit health professionals, the public health community, consumers and government officials.","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Newborn Screening"},{"id":1437,"resourceId":932,"resourceName":"March of Dimes","descriptionText":"The <a href='http://www.marchofdimes.com/pnhec/4439_1213.asp ' target='_blank'>March of Dimes (MOD)</a>&nbsp;has a fact sheet on cystic fibrosis.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1439,"resourceId":2088,"resourceName":"Cystic Fibrosis Care Center Network","descriptionText":"The <a href='https://www.cff.org/Care-Centers/Find-A-CF-Care-Center/' target='_blank'>Cystic Fibrosis Foundation</a> <span style=\"color: #333333; font-family: Roboto, Verdana, Geneva, Tahoma, sans-serif;\">has a directory of cystic fibrosis care centers nationwide, including programs for children and adults. These centers provide specialized care and also participate in clinical research.</span>","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1450,"resourceId":2098,"resourceName":"NIDDK Cystic fibrosis research program","descriptionText":"<a href='http://www2.niddk.nih.gov/Research/ScientificAreas/GeneticGeneTherapy/CFXX.htm ' target='_blank'>The Cystic Fibrosis Research Program</a> is funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to support investigator-initiated research grants encompassing both fundamental and clinical studies of the etiology, molecular pathogenesis, pathophysiology, diagnosis, and treatment of cystic fibrosis and its complications.","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":1457,"resourceId":2104,"resourceName":"Genetic Services","descriptionText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by the <a href='http://www.acmg.net/ACMG/Genetic_Services_Directory_Search.aspx' target='_blank'>American College of Medical Genetics</a> and the&nbsp;<a href='https://www.findageneticcounselor.com/' target='_blank'>National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also&nbsp;<a href='https://ghr.nlm.nih.gov/primer#consult' target='_blank'>learn more about genetic consultations</a>&nbsp;from Genetics Home Reference.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1526,"resourceId":2158,"resourceName":"Genetic Testing Registry","descriptionText":"The <a href='http://www.ncbi.nlm.nih.gov/gtr/conditions/C0010674' target='_blank'>Genetic Testing Registry</a> (GTR) provides information about the genetic tests for this condition. The intended audience for the GTR is health care providers and researchers. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.<br />\r\n","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Testing Resources"},{"id":1527,"resourceId":2159,"resourceName":"National Organization for Rare Disorders","descriptionText":"The <a href='http://www.rarediseases.org/rare-disease-information/rare-diseases/byID/24/viewAbstract' target='_blank'>National Organization for Rare Disorders</a> (NORD) has a report for patients and families about this condition. NORD is a patient advocacy organization for individuals with rare diseases and the organizations that serve them.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1529,"resourceId":2128,"resourceName":"MedlinePlus","descriptionText":"<a href='http://www.nlm.nih.gov/medlineplus/cysticfibrosis.html' target='_blank'>MedlinePlus</a> was designed by the National Library of Medicine to help you research your health questions, and it provides more information about this topic.\r\n<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1531,"resourceId":2162,"resourceName":"Medscape Reference","descriptionText":"<a href='http://emedicine.medscape.com/article/1001602-overview' target='_blank'>Medscape Reference</a> provides information on this topic. You may need to register to view the medical textbook, but registration is free.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=586' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1535,"resourceId":2166,"resourceName":"ACTion (ACT) sheet","descriptionText":"An  <a href='https://www.acmg.net/PDFLibrary/Cystic-Fibrosis-ACT-Sheet.pdf' target='_blank'>ACTion (ACT) sheet </a> is available for this condition that describes the short-term actions a health professional should follow when an infant has a positive newborn screening result. ACT sheets were developed by experts in collaboration with the American College of Medical Genetics.","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Newborn Screening"},{"id":1537,"resourceId":2168,"resourceName":"GeneReviews","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&part=cf' target='_blank'>GeneReviews</a> provides current, expert-authored, peer-reviewed, full-text articles describing the application of genetic testing to the diagnosis, management, and genetic counseling of patients with specific inherited conditions.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1546,"resourceId":2174,"resourceName":"Algorithm","descriptionText":"An <a href='https://www.acmg.net/PDFLibrary/IRT_Algorithm.pdf' target='_blank'>Algorithm</a> flowchart is available for this condition for determining the final diagnosis in an infant with a positive newborn screening result. Algorithms are developed by experts in collaboration with the American College of Medical Genetics.","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Newborn Screening"},{"id":1547,"resourceId":2175,"resourceName":"Screening, Technology And Research in Genetics (STAR-G) Project","descriptionText":"The <a href='http://www.newbornscreening.info/Parents/otherdisorders/CF.htm' target='_blank'>Screening, Technology And Research in Genetics (STAR-G) Project</a> has a fact sheet on this condition, which was written specifically for families that have received a diagnosis as a result of newborn screening. This fact sheet provides general information about the condition and answers questions that are of particular concern to parents.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1549,"resourceId":2177,"resourceName":"National Human Genome Research Institute","descriptionText":"The <a href='http://www.genome.gov/10001213' target='_blank'>National Human Genome Research Institute's</a> (NHGRI) website has an information page on this topic. NHGRI is part of the National Institutes of Health and supports research on the structure and function of the human genome and its role in health and disease.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1558,"resourceId":2184,"resourceName":"National Heart, Lung, and Blood Institute","descriptionText":"The <a href='http://www.nhlbi.nih.gov/health/health-topics/topics/cf/' target='_blank'>National Heart, Lung, and Blood Institute</a> (NHLBI) has information on this topic. NHLBI is part of the National Institutes of Health and supports research, training, and education for the prevention and treatment of heart, lung, and blood diseases.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1836,"resourceId":3032,"resourceName":"Catalyst Center","descriptionText":"The <a href='http://hdwg.org/catalyst/resources' target='_blank'>Catalyst Center</a> is dedicated to improving health care coverage and financing for children and youth with special health care needs. They provide a directory of organizations, sorted by state, which may be able to provide assistance to families with questions about coverage and financing of care for children with special health concerns.","resourceClassificationName":"Living With","resourceClassificationSectionName":"Financial Resources"},{"id":1837,"resourceId":3033,"resourceName":"Family Voices","descriptionText":"<a href='http://www.familyvoices.org/states' target='_blank'>Family Voices</a> aims to achieve family-centered care for all children and youth with special health care needs and/or disabilities. They provide families with resources and support to make informed decisions, advocate for improved public and private policies, and build partnerships among families and professionals. Click on the link to find a Family-to-Family Health Information Center in your state.","resourceClassificationName":"Living With","resourceClassificationSectionName":"Parent and Caregiver Resources"},{"id":1838,"resourceId":3034,"resourceName":"Institute for Community Inclusion","descriptionText":"The <a href='http://www.communityinclusion.org' target='_blank'>Institute for Community Inclusion (ICI)</a> supports the rights of children and adults with disabilities to participate in all aspects of the community. As practitioners, researchers, and teachers, they form partnerships with individuals, families, and communities.","resourceClassificationName":"Living With","resourceClassificationSectionName":"Community Resources"},{"id":1842,"resourceId":3038,"resourceName":"GARD’s Genetics Resources Page","descriptionText":"GARD's <a href='https://rarediseases.info.nih.gov/resources/3/genetics-resources' target='_blank'>Genetics Resources Web page</a> offers a collection of resources that provide information on genes, genomics, and genetic conditions, including family health history tools, a glossary of genetic terms, and more.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1843,"resourceId":3039,"resourceName":"Patient Advocate Foundation","descriptionText":"The&nbsp;Patient Advocate Foundation's&nbsp;Web site&nbsp;features tools that generate a list of national and regional resources which are dedicated to improving access to quality care and decreasing the financial burden of medical treatment. They have separate tools for those who are uninsured and underinsured:<br />\r\n<a href='http://www.patientadvocate.org/NURD/index2.php?application=uninsured' target='_blank'>National Uninsured Resource Directory</a><br /><a href='http://www.patientadvocate.org/NURD/index2.php?application=underinsured' target='_blank'>National Underinsured Resource Directory</a><br />","resourceClassificationName":"Living With","resourceClassificationSectionName":"Financial Resources"},{"id":1846,"resourceId":3031,"resourceName":"Genetics Education Materials for School Success","descriptionText":"The <a href='http://www.gemssforschools.org/conditions/cystic-fibrosis/default' target='_blank'>Genetics Education Materials for School Success (GEMSS)</a> aims to assure that all children with genetic health conditions succeed in school-life. Their Web site offers general and condition-specific education resources to help teachers and parents better understand the needs of students who have genetic conditions.","resourceClassificationName":"Living With","resourceClassificationSectionName":"Education Resources"},{"id":2097,"resourceId":27,"resourceName":"Cystic Fibrosis Foundation","descriptionText":"The <a href='https://www.cff.org/Our-Research/North-American-CF-Conference/' target='_blank'>North American Cystic Fibrosis Conference</a>&nbsp;is held every year to help advance CF research and care. This meeting is sponsored by the Cystic Fibrosis Foundation. It brings together scientists, clinicians and caregivers from around the world to discuss and share ideas on the latest advances in CF research, care and drug development and to exchange ideas about ways to improve the health and quality of life for people with CF.","resourceClassificationName":"News & Events","resourceClassificationSectionName":"Other Conferences"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/OMIM:219700' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2161,"resourceId":3369,"resourceName":"HealthWell Foundation","descriptionText":"The <a href='http://www.healthwellfoundation.org/cystic-fibrosis' target='_blank'>HealthWell Foundation</a> provides financial assistance for underinsured patients living with chronic and life-altering conditions. They offer help with drug copayments, deductibles, and health insurance premiums for patients with specific diseases. The disease fund status can change over time, so you may need to check back if funds are not currently available.","resourceClassificationName":"Living With","resourceClassificationSectionName":"Financial Resources"},{"id":2162,"resourceId":3371,"resourceName":"The Assistance Fund","descriptionText":"<a href='https://tafcares.org/patients/covered-diseases/' target='_blank'>The Assistance Fund</a> provides various services, including education and financial aid, to help patients with a chronic or serious illness cover the cost of FDA-approved medications. Patients must be U.S citizens or permanent residents.","resourceClassificationName":"Living With","resourceClassificationSectionName":"Financial Resources"},{"id":2316,"resourceId":3552,"resourceName":"Diagnosis of Cystic Fibrosis: Consensus Guidelines from the Cystic Fibrosis Foundation","descriptionText":"Farrell PM, White TB, Ren CL, Hempstead SE, Accurso F, Derichs N, Howenstine M, McColley SA, Rock M, Rosenfeld M, Sermet-Gaudelus I, Southern KW, Marshall BC, and Sosnay PR.&nbsp;<a href='http://www.jpeds.com/article/S0022-3476(16)31048-4/pdf' target='_blank'>Diagnosis of Cystic Fibrosis: Consensus Guidelines from the Cystic Fibrosis Foundation</a> <em>J Pediatr</em> 2017;181 S:S4-15.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2523,"resourceId":2128,"resourceName":"MedlinePlus","descriptionText":"<a href='https://medlineplus.gov/directories.html' target='_blank'>MedlinePlus</a> has a list of directories to help you find health professionals, services, and facilities. This website is supported by the National Library of Medicine to help you research your health questions.&nbsp;","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":2722,"resourceId":4053,"resourceName":"Patient Registry","descriptionText":"A registry supports research by collecting of information about patients that share something in common, such as being diagnosed with Cystic fibrosis. The type of data collected can vary from registry to registry and is based on the goals and purpose of that registry. Some registries collect contact information while others collect more detailed medical information. <a href=\"https://www.nih.gov/health-information/nih-clinical-research-trials-you/list-registries\" target=\"_blank\">Learn more about registries</a>.<br />\r\n<br />\r\nRegistries for&nbsp;Cystic fibrosis:<br />\r\n<a href='http://www.cff.org/LivingWithCF/CareCenterNetwork/PatientRegistry/' target='_blank'>Cystic Fibrosis Foundation Patient Registry </a><br />&nbsp;","resourceClassificationName":"Research","resourceClassificationSectionName":"Patient Registry"}],"overviewQuestion":{"questionId":30,"questionText":"What is cystic fibrosis?","answerText":"<strong>Cystic fibrosis </strong>(CF) is a genetic disorder that causes mucus to build up and damage organs in the body, particularly  the lungs and pancreas. Signs and symptoms may include <span style=\"font-size: 12pt;\">salty-tasting skin; p</span><span style=\"font-size: 12pt;\">ersistent coughing; f</span><span style=\"font-size: 12pt;\">requent lung infections; w</span><span style=\"font-size: 12pt;\">heezing or shortness of breath; p</span><span style=\"font-size: 12pt;\">oor growth; weight loss; </span><span style=\"font-size: 12pt;\">greasy, bulky stools; difficulty with bowel movements; and in&nbsp;</span>males,&nbsp;<a title=\"Fertility in Men With CF\" href=\"https://www.cff.org/Living-with-CF/Reproductive-Health-and-Fertility/CF-and-the-Male-Reproductive-System/Fertility-in-Men-With-CF/\" style=\"font-size: 12pt;\">infertility</a>.&nbsp;Over time, mucus buildup and infections can lead to permanent lung damage, including the formation of scar tissue (fibrosis) and cysts in the lungs. CF is caused by mutations in the <a href=\"http://ghr.nlm.nih.gov/gene/CFTR\" target=\"_blank\"><em>CFTR</em></a> gene and inheritance is autosomal recessive.[24][13438][25] Treatment aims to relieve symptoms and usually includes respiratory therapies, inhaled medicines,&nbsp;<a title=\"Enzymes\" href=\"https://www.cff.org/Living-with-CF/Treatments-and-Therapies/Nutrition/Enzymes/\" style=\"font-size: 12pt;\">pancreatic enzyme supplement</a>, and nutritional supplements. Newer medications such as&nbsp;<a title=\"CFTR Modulators\" href=\"https://www.cff.org/Living-with-CF/Treatments-and-Therapies/CFTR-Modulators/\">CFTR modulators</a>&nbsp;have been approved for use in the United States. Ongoing research is focused on finding a cure for the disease.[13438]","dateModified":"2017-09-22T00:00:00"},"basicQuestions":[{"questionId":31,"questionText":"What causes cystic fibrosis?","answerText":"<a href=\"http://www.genome.gov/glossary.cfm?key=mutation\" target=\"_blank\">Mutations</a> in a <a href=\"http://www.genome.gov/glossary.cfm?key=gene\" target=\"_blank\">gene</a>&nbsp;called&nbsp;<a href=\"http://ghr.nlm.nih.gov/gene=cftr\" target=\"_blank\">cystic fibrosis transmembrane regulator (CFTR)</a>&nbsp;cause&nbsp;CF.&nbsp;More than 900 mutations in this gene have been found. This gene provides the instructions for the CFTR protein.&nbsp;In normal cells, the CFTR protein acts as a channel that allows cells to release chloride and other ions. But in people with CF, this protein is defective and the cells do not release the chloride. The result is an improper salt balance in the cells which leads to&nbsp;thick, sticky mucus.[25]&nbsp;<span>When mucus clogs the lungs, it can make breathing very difficult, and causes bacteria to get stuck in the airways, resulting in inflammation&nbsp;and infections. Over time, mucus buildup and infections can lead to permanent lung damage, including the formation of scar tissue (fibrosis) and cysts in the lungs. Mucus can also block the digestive tract and pancreas, leading to digestive problems.[24]&nbsp;</span>","dateModified":"2017-05-23T00:00:00","resourceClassificationName":"Cause","references":[{"referenceId":24,"authors":"","articleTitle":"Cystic fibrosis","bookWebsiteJournalTitle":"Genetics Home Reference","date":"2012","volume":"","pages":"","url":"https://ghr.nlm.nih.gov/condition/cystic-fibrosis","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":25,"authors":"","articleTitle":"Learning about Cystic Fibrosis","bookWebsiteJournalTitle":"National Human Genome Research Institute","date":"2013","volume":"","pages":"","url":"http://www.genome.gov/page.cfm?pageID=10001213","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":10598,"questionText":"How is cystic fibrosis (CF) inherited?","answerText":"CF is inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=\"_blank\">autosomal recessive</a> manner.[989][24][11417] This means that to have CF, a person must have a <a href=\"http://www.genome.gov/Glossary/index.cfm?id=134\" target=\"_blank\">mutation</a> in both copies of the <a href=\"https://ghr.nlm.nih.gov/gene/CFTR\" target=\"_blank\"><em>CFTR</em> gene</a> in each cell. People with CF inherit one mutated copy of the gene from each parent, who is referred to as a <a href=\"http://www.genome.gov/glossary/?id=23\" target=\"_blank\">carrier</a>. Carriers of an autosomal recessive condition typically do not have any signs or symptoms. <br />\r\n<br />\r\nWhen two carriers of an autosomal recessive condition have children, each child has a:\r\n<ul>\r\n    <li>25% (1 in 4) chance to have CF</li>\r\n    <li>50% (1 in 2) chance to be a carrier of CF like each parent</li>\r\n    <li>25% chance to not have CF&nbsp;<em>and</em>&nbsp;not be a carrier</li>\r\n</ul>\r\nWhen a carrier of CF has a child with a person with CF, each child has a:<br />\r\n<ul>\r\n    <li>50% (1 in 2) chance to have CF</li>\r\n    <li>50% (1 in 2) chance to be a carrier of CF</li>\r\n</ul>\r\nA helpful diagram/pictures of both of these situations can be found on the <a href=\"https://www.cff.org/What-is-CF/Testing/Carrier-Testing-for-CF/\" target=\"_blank\">Carrier Testing for CF</a>&nbsp;page of the <a href=\"https://www.cff.org/\" target=\"_blank\">Cystic Fibrosis Foundation</a> website.","dateModified":"2017-05-16T00:00:00","resourceClassificationName":"Inheritance","references":[{"referenceId":24,"authors":"","articleTitle":"Cystic fibrosis","bookWebsiteJournalTitle":"Genetics Home Reference","date":"2012","volume":"","pages":"","url":"https://ghr.nlm.nih.gov/condition/cystic-fibrosis","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":989,"authors":"Moskowitz SM, Chmiel JF, Sternen DL, Cheng E, and Cutting GR","articleTitle":"CFTR-Related Disorders","bookWebsiteJournalTitle":"GeneReviews","date":"February 19 2008","volume":"","pages":"","url":"https://www.ncbi.nlm.nih.gov/books/NBK1250/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":11417,"authors":"","articleTitle":"CF Genetics","bookWebsiteJournalTitle":"Cystic Fibrosis Foundation","date":"","volume":"","pages":"","url":"https://www.cff.org/What-is-CF/CF-Genetics/","dateAccessed":"2016-04-12T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":1665,"questionText":"What are the current genetic tests for cystic fibrosis?","answerText":"<a href=\"http://www.ghr.nlm.nih.gov/gene=cftr\" target=_blank><i>CFTR</i></a> is the only gene known to be associated with cystic fibrosis. Reasons for genetic testing or screening of this gene may include:[989] \r\n<p></p>\r\n<ul>\r\n<li>Diagnosis in individuals with symptoms of CF or with <a href=\"http://ghr.nlm.nih.gov/condition/congenital-bilateral-absence-of-the-vas-deferens\" target=_blank>congenital absence of the vas deferens (CAVD)</a> \r\n<li>Prenatal diagnosis of a fetus at risk \r\n<li>Carrier testing for at-risk relatives and their reproductive partners or for &nbsp;population screening \r\n<li><a href=\"https://www.asrm.org/FACTSHEET_Preimplantation_genetic_testing/\" target=_blank>Preimplantation genetic diagnosis</a> for pregnancies at high risk for CF</li></ul>\r\n<p>More information about genetic testing for cystic fibrosis is available on The National Human Genome Research Institute’s Web site and can be viewed by <a href=\"http://www.genome.gov/10001213#al-2\" target=_blank>clicking here</a>.","dateModified":"2012-06-22T09:56:00","resourceClassificationName":"Diagnosis","references":[{"referenceId":989,"authors":"Moskowitz SM, Chmiel JF, Sternen DL, Cheng E, and Cutting GR","articleTitle":"CFTR-Related Disorders","bookWebsiteJournalTitle":"GeneReviews","date":"February 19 2008","volume":"","pages":"","url":"https://www.ncbi.nlm.nih.gov/books/NBK1250/","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":10599,"questionText":"What is the carrier frequency of cystic fibrosis (CF) and the number of people who have cystic fibrosis in the United States&nbsp;?","answerText":"More than 30,000 people in USA are living with cystic fibrosis (more than 70,000 worldwide).[13438]<br />\r\n<br />\r\nIn the United States, the following are statistics about the chance to be a carrier of a <a href=\"https://ghr.nlm.nih.gov/gene/CFTR\" target=\"_blank\"><em>CFTR</em> gene</a> mutation:[11415][11416]<br />\r\n<ul>\r\n    <li>1 in 29 Caucasian-Americans</li>\r\n    <li>1 in 46 Hispanic-Americans</li>\r\n    <li>1 in 65 African-Americans</li>\r\n    <li>1 in 90 Asian-Americans</li>\r\n</ul>","dateModified":"2017-05-23T00:00:00","resourceClassificationName":"Statistics","references":[{"referenceId":11415,"authors":"American College of Obstetricians and Gynecologists","articleTitle":"Update on carrier screening for cystic fibrosis. Committee Opinion No. 486","bookWebsiteJournalTitle":"ObstetGynecol","date":"2011","volume":"117","pages":"1028-31","url":"http://www.acog.org/Resources-And-Publications/Committee-Opinions/Committee-on-Genetics/Update-on-Carrier-Screening-for-Cystic-Fibrosis","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":11416,"authors":"","articleTitle":"Carrier testing for CF","bookWebsiteJournalTitle":"Cystic Fibrosis Foundation","date":"","volume":"","pages":"","url":"https://www.cff.org/What-is-CF/Testing/Carrier-Testing-for-CF/","dateAccessed":"2016-04-12T00:00:00","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":13438,"authors":"","articleTitle":"About Cystic Fibrosis","bookWebsiteJournalTitle":"Cystic Fibrosis Foundation","date":"","volume":"","pages":"","url":"https://www.cff.org/What-is-CF/About-Cystic-Fibrosis/","authors2":"","placeOfPublication":"","publisher":""}]}],"references":[],"relatedDiseases":[],"gardCases":[],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":13781,"phenoTypeName":"Biliary cirrhosis","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":3592,"phenoTypeName":"Decreased circulating antibody level","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":3878,"phenoTypeName":"Exocrine pancreatic insufficiency","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":10673,"phenoTypeName":"Immunodeficiency","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":13413,"phenoTypeName":"Malabsorption","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":8076,"phenoTypeName":"Pulmonary fibrosis","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":8075,"phenoTypeName":"Recurrent respiratory infections","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":13042,"phenoTypeName":"Dehydration","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":8115,"phenoTypeName":"Hepatomegaly","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13731,"phenoTypeName":"Asthma","percentRanges":"-"},{"phenoTypeId":4,"phenoTypeName":"Autosomal recessive inheritance","percentRanges":"-"},{"phenoTypeId":13740,"phenoTypeName":"Bronchiectasis","percentRanges":"-"},{"phenoTypeId":10182,"phenoTypeName":"Chronic lung disease","percentRanges":"-"},{"phenoTypeId":8982,"phenoTypeName":"Cor pulmonale","percentRanges":"-"},{"phenoTypeId":6286,"phenoTypeName":"Elevated sweat chloride","percentRanges":"-"},{"phenoTypeId":4081,"phenoTypeName":"Failure to thrive","percentRanges":"-"},{"phenoTypeId":13830,"phenoTypeName":"Hypercalciuria","percentRanges":"-"},{"phenoTypeId":10943,"phenoTypeName":"Male infertility","percentRanges":"-"},{"phenoTypeId":10366,"phenoTypeName":"Meconium ileus","percentRanges":"-"},{"phenoTypeId":13415,"phenoTypeName":"Rectal prolapse","percentRanges":"-"},{"phenoTypeId":10189,"phenoTypeName":"Recurrent bronchopulmonary infections","percentRanges":"-"},{"phenoTypeId":10186,"phenoTypeName":"Recurrent pneumonia","percentRanges":"-"}],"medicalProducts":[{"productId":525,"genericName":"Aztreonam","tradeName":"Cayston","tradeLink":"http://www.gilead.com/products/?theProd=cayston#cayston","manufacturer":"Gilead Sciences","sponsor":"Gilead Sciences (formerly Corus Pharma)","indication":"To improve respiratory symptoms in cystic fibrosis (CF) patients with Pseudomonas aeruginosa","drugInformationLink":"http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=16082","medlinePlusLink":""},{"productId":545,"genericName":"Ivacaftor","tradeName":"Kalydeco","tradeLink":"http://www.kalydeco.com/","manufacturer":"","sponsor":"Vertex Pharmaceuticals, Inc.","indication":"August 2018, ivacaftor (KALYDECO) received expanded approval for the treatment of cystic fibrosis (CF) in patients age 12 months and older who have one mutation in the CFTR gene that is responsive to ivacaftor potentiation based on clinical and/or in vitro assay data. It is a cystic fibrosis transmembrane conductance regulator (CFTR) potentiator.","drugInformationLink":"https://druginfo.nlm.nih.gov/drugportal/name/kalydeco","medlinePlusLink":"https://medlineplus.gov/druginfo/meds/a612012.html"},{"productId":625,"genericName":"Lumacaftor/ivacaftor","tradeName":"Orkambi","tradeLink":"http://www.orkambi.com/","manufacturer":"","sponsor":"Vertex Pharmaceuticals Inc.","indication":"August 2018, lumacaftor/ivacaftor (Orkambi) received expanded approval for the treatment of cystic fibrosis (CF) in patients age 2 years and older who are homozygous for the F508del mutation in the CFTR gene.","drugInformationLink":"https://druginfo.nlm.nih.gov/drugportal/rn/1815566-23-4","medlinePlusLink":"https://medlineplus.gov/druginfo/meds/a615037.html"},{"productId":192,"genericName":"Dornase alfa","tradeName":"Pulmozyme®","tradeLink":"http://www.pulmozyme.com/","manufacturer":"","sponsor":"Genentech, Inc.","indication":"In conjunction with standard therapies in the management of cystic fibrosis patients to reduce the frequency of respiratory infections requiring parenteral antibiotics and to improve pulmonary function.","drugInformationLink":"http://druginfo.nlm.nih.gov/drugportal/dpdirect.jsp?name=Pulmozyme","medlinePlusLink":"http://www.nlm.nih.gov/medlineplus/druginfo/meds/a694002.html"},{"productId":712,"genericName":"Tezacaftor and Ivacaftor combination therapy","tradeName":"Symdeko","tradeLink":"https://www.symdeko.com/","manufacturer":"","sponsor":"Vertex Pharmaceuticals Inc.","indication":"February 2018 approved for the treatment of patients with cystic fibrosis (CF) aged 12 years and older who are homozygous for the F508del mutation or who have at least one mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene that is responsive to tezacaftor/ivacaftor based on in vitro data and/or clinical evidence.","drugInformationLink":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=302ae804-37db-44fd-ac2f-3dbdeda9aa4b","medlinePlusLink":""},{"productId":351,"genericName":"Tobramycin for inhalation","tradeName":"Tobi®","tradeLink":"http://www.tobitime.com/index.jsp","manufacturer":"","sponsor":"Novartis Pharmaceuticals Corp","indication":"Management of cystic fibrosis patients with P.aeruginosa.","drugInformationLink":"http://druginfo.nlm.nih.gov/drugportal/dpdirect.jsp?regno=032986564","medlinePlusLink":"http://www.nlm.nih.gov/medlineplus/druginfo/meds/a681003.html"}],"EncodedName":"Cystic_fibrosis"}